Best of October 2025: Top 5 Insights In Clinical Supply Chain & Logistics

#1 - What Can The Tech Sector's 'Minimally Viable' Concept Teach Biopharma?

Learn how adopting a “minimally viable” approach can help biopharma and life science organizations accelerate innovation, reduce costs, and validate ideas faster without compromising scientific rigor or patient safety.

#2 - Improving Site Efficiency With Automated Drug Resupply And Forecasting

Explore how Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.

#3 - Careful Outsourcing Proves Key To Targeted Protein Degradation Drug Development

Discover how partnerships — especially with capable CROs — as well as resilient supply chains, digital enablement, regulatory foresight, and specialized talent impact the success of targeted protein degradation therapies.

#4 - How Sanofi Leveraged Suvoda IRT To Improve Clinical Supply Management

In this case study, learn how streamlined clinical supply chain management helped accelerate study timelines, reduce costs, and support global treatment delivery through a strategic technology partnership.

#5 - Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots

The terms “confirmatory" and "conformance" batches are inconsistently used in the industry. Since process validation is essential for maintaining compliance and detecting variability, we must work toward harmonization of the terms to avoid confusion.